News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
33,430 Results
Type
Article (1104)
Company Profile (1)
Press Release (32324)
Multimedia
Podcasts (7)
Webinars (1)
Section
Business (9376)
Career Advice (26)
Deals (1425)
Drug Delivery (2)
Drug Development (4440)
Employer Resources (7)
FDA (570)
Job Trends (652)
News (15419)
Policy (1035)
Tag
Academia (85)
Accelerated approval (3)
Adcomms (7)
Allergies (6)
Alliances (1586)
ALS (6)
Alzheimer's disease (319)
Antibody-drug conjugate (ADC) (16)
Approvals (570)
Artificial intelligence (12)
Autoimmune disease (6)
Bankruptcy (8)
Best Places to Work (614)
Biosimilars (2)
Biotechnology (3)
Bladder cancer (10)
Brain cancer (5)
Breast cancer (60)
Cancer (337)
Cardiovascular disease (16)
Career advice (21)
CAR-T (20)
Cell therapy (49)
Clinical research (4006)
Collaboration (63)
Compensation (6)
Complete response letters (7)
COVID-19 (67)
CRISPR (4)
C-suite (20)
Cystic fibrosis (2)
Data (574)
Depression (29)
Diabetes (15)
Diagnostics (264)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (6)
Drug pricing (1)
Duchenne muscular dystrophy (7)
Earnings (6839)
Editorial (1)
Employer resources (4)
Events (10374)
Executive appointments (18)
FDA (736)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (50)
Gene editing (7)
Generative AI (1)
Gene therapy (21)
GLP-1 (34)
Government (84)
Guidances (38)
Healthcare (946)
Huntington's disease (10)
IgA nephropathy (4)
Immunology and inflammation (6)
Immuno-oncology (1)
Indications (6)
Infectious disease (79)
Inflammatory bowel disease (7)
Influenza (5)
Intellectual property (10)
Interviews (4)
IPO (853)
IRA (2)
Job creations (73)
Job search strategy (21)
JPM (2)
Kidney cancer (5)
Layoffs (14)
Legal (233)
Liver cancer (2)
Lung cancer (48)
Lymphoma (64)
Machine learning (4)
Management (3)
Manufacturing (25)
MASH (2)
Medical device (639)
Medtech (643)
Mergers & acquisitions (608)
Metabolic disorders (42)
Multiple sclerosis (9)
Neurodegenerative disease (56)
Neuropsychiatric disorders (22)
Neuroscience (435)
NextGen: Class of 2026 (201)
Non-profit (131)
Obesity (23)
Opinion (5)
Ovarian cancer (4)
Pain (9)
Pancreatic cancer (12)
Parkinson's disease (15)
Partnered (3)
Patents (30)
Patient recruitment (22)
Peanut (3)
People (1242)
Phase 1 (1307)
Phase 2 (1895)
Phase 3 (1252)
Pipeline (453)
Policy (4)
Postmarket research (98)
Preclinical (472)
Prostate cancer (16)
Psychedelics (31)
Radiopharmaceuticals (16)
Rare diseases (51)
Real estate (165)
Recruiting (3)
Regulatory (908)
Reports (1)
Research institute (72)
Resumes & cover letters (2)
Rett syndrome (2)
RNA editing (1)
RSV (2)
Schizophrenia (7)
Series A (12)
Series B (6)
Sickle cell disease (4)
Special edition (1)
Spinal muscular atrophy (55)
Sponsored (1)
Startups (105)
Supply chain (5)
The Weekly (7)
Vaccines (15)
Venture capital (1)
Weight loss (4)
Women's health (2)
Date
Today (6)
Last 7 days (32)
Last 30 days (150)
Last 365 days (2083)
2026 (292)
2025 (2125)
2024 (2628)
2023 (3004)
2022 (3047)
2021 (2837)
2020 (2626)
2019 (2069)
2018 (1524)
2017 (1505)
2016 (1498)
2015 (1860)
2014 (1353)
2013 (903)
2012 (1043)
2011 (1046)
2010 (862)
Location
Africa (35)
Alabama (2)
Arizona (10)
Asia (2214)
Australia (991)
California (1137)
Canada (176)
China (52)
Colorado (20)
Connecticut (30)
Delaware (54)
Europe (3157)
Florida (148)
Georgia (30)
Idaho (2)
Illinois (39)
Indiana (38)
Japan (31)
Kansas (61)
Kentucky (4)
Louisiana (1)
Maryland (42)
Massachusetts (519)
Michigan (8)
Minnesota (32)
Missouri (14)
Nebraska (2)
Nevada (15)
New Hampshire (3)
New Jersey (266)
New Mexico (1)
New York (193)
North Carolina (80)
Northern California (577)
Ohio (6)
Oregon (2)
Pennsylvania (114)
South America (54)
South Carolina (1)
Southern California (443)
Tennessee (4)
Texas (91)
United States (2980)
Utah (20)
Virginia (3)
Washington State (67)
Wisconsin (4)
33,430 Results for "pt kalbe farma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
GC Cell Signs an MOU with PT Bifarma Adiluhung, an affiliate of KALBE group
GC Cell, a fully integrated cell and gene therapy pioneer, is proud to announce the establishment of an MOU for strategic partnership with Bifarma, a frontrunner in stem cell therapy within Indonesia with comprehensive capabilities in R&D, GMP-compliant manufacturing, and the commercialization of cell therapies.
June 19, 2024
·
4 min read
Press Releases
Results from Phase 1 Multiple-Dose Study of PT00114
December 10, 2025
·
4 min read
Press Releases
Promontory Therapeutics Announces Interim Efficacy Requirement Reached on Phase 2 Study of PT-112 Monotherapy in Patients with Recurrent Thymoma
December 23, 2025
·
4 min read
Press Releases
PAQ Therapeutics Announces Series B Extension, Bringing Total Series B Financing to $77 Million; First Patient Dosed in Phase 1 Trial of PT0511, a Pan-KRAS Degrader
January 22, 2026
·
2 min read
Press Releases
Phanes Therapeutics Announces Positive Phase 2 Results of Spevatamig (PT886) in Combination with Chemotherapy in Frontline (1L) Treatment of Metastatic PDAC at ASCO GI 2026
January 12, 2026
·
4 min read
Press Releases
BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT / 2:15 pm ET, in San Francisco, CA
January 9, 2026
·
1 min read
Press Releases
Phanes Therapeutics to Present Phase 1/2 Study Results of Spevatamig (PT886) in Combination with Chemotherapy in Frontline (1L) Treatment of Metastatic PDAC at ASCO GI 2026
December 10, 2025
·
2 min read
Press Releases
Coag-Sense® PT/INR Monitoring System Approved for Patient Self-Testing in Europe
September 3, 2025
·
2 min read
Policy
Genexine and KGbio received the first market approval for novel long-acting Erythropoietin, Efepoetin alfa, from The Indonesian Food and Drug Authority (BPOM)
Genexine together with PT Kalbe Genexine Biologics, a joint venture clinical-stage biotechnology company between Genexine and PT Kalbe Farma that focused on bringing biologics medical innovation to international markets, announced the approval of its long-acting erythropoietin, Efepoetin alfa, by the Indonesian Ministry of Food and Drug Safety for the treatment of chronic kidney disease induced anemia in non-dialysis patients.
October 23, 2023
·
5 min read
Press Releases
PerkinElmer Acquires Project Farma, Expanding Its OneSource Professional Services Offering for the Life Sciences Industry
March 11, 2025
·
3 min read
1 of 3,343
Next
